GlassScriptPhysician profile
Jeffrey M Lubow
NPI 1467644328
$1,648.54
in general payments reported to CMS, 2019-2025
20 companies · $116 in 2025
The $116 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10.70 · 2022: $433 · 2023: $893 · 2024: $195 · 2025: $116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,045 · Education: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,044.59 |
| Education | $159.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $328.01 | 2022-2024 | Veozah, Myrbetriq |
| Gynesonics, INC. | $261.87 | 2022-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Sumitomo Pharma America, INC. | $221.80 | 2023-2024 | Myfembree |
| Myriad Women'S Health, INC. | $125.00 | 2023 | Myrisk |
| Pfizer INC. | $102.40 | 2022-2023 | |
| Aspira Women'S Health INC | $76.25 | 2022 | |
| Abbvie INC. | $68.56 | 2022-2023 | |
| Hologic Sales and Service, LLC | $67.83 | 2022-2023 | Novasure, Myosure Tissue Removal Device, Fluent Fluid Management System |
| Exeltis, USA INC. | $58.41 | 2022-2023 | Slynd |
| Currax Pharmaceuticals LLC | $57.15 | 2022-2023 | Contrave |
| Mayne Pharma Commercial LLC | $54.24 | 2023 | |
| Ethicon US, LLC | $40.27 | 2022 | |
| Therapeuticsmd, INC. | $35.45 | 2022 | |
| Shield Therapeutics INC | $31.21 | 2023 | Accrufer |
| Merck Sharp & Dohme LLC | $29.24 | 2022-2023 | Gardasil 9 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $24.68 | 2022-2023 | |
| Coopersurgical, INC. | $19.30 | 2023 | Endosee |
| Exact Sciences Corporation | $18.20 | 2024 | Cologuard Collection Kit |
| Organon LLC | $17.97 | 2023 | Nexplanon |
| Daiichi Sankyo INC. | $10.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Lubow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.